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Summary
Thesynthesisof proteins in theendoplasmic reticulum
(ER) is limited by the rate of correct disulfide bond for-
mation. This process is carried out by protein disulfide
isomerases, a family of ER proteins which includes
general enzymes such as PDI that recognize unfolded
proteins and others that are selective for specific pro-
teins or classes. Using small-angle X-ray scattering
and X-ray crystallography, we report the structure
of a selective isomerase, ERp57, and its interactions
with the lectin chaperone calnexin. Using isothermal
titration calorimetry and NMR spectroscopy, we show
that the b0 domain of ERp57 binds calnexin withmicro-
molar affinity through a conserved patch of basic resi-
dues. Disruption of this binding site by mutagenesis
abrogates folding of RNase B in an in vitro assay. The
relative positions of the ERp57 catalytic sites and cal-
nexin binding site suggest that activation by calnexin
is due to substrate recruitment rather than a direct
stimulation of ERp57 oxidoreductase activity.
Introduction
In order to fold in the oxidative environment of the
endoplasmic reticulum (ER), proteins need to acquire
the proper arrangement of cysteine disulfide bonds.
To meet this challenge, the cell produces a large number
of different ER protein disulfide isomerases to catalyze
the oxidation and isomerization of disulfides (Ellgaard
and Ruddock, 2005; Tu and Weissman, 2004). The
best-known and most abundant of these is the primary
oxidant PDI. For N-glycosylated proteins, a dedicated
pathway exists mediated by the protein disulfide isom-
erase ERp57, the lectin-like molecular chaperones cal-
nexin (CNX) and calreticulin (CRT), and UDP-glucose:
glycoprotein glucosyltransferase (UGGT) (Ellgaard and
Frickel, 2003; Helenius and Aebi, 2004; High et al.,
2000; Parodi, 2000; Schrag et al., 2003). Following syn-
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4 These authors contributed equally to this work.thesis and N-glycosylation, the glycan is trimmed by
the removal of two glucose residues to generate a
Glc1Man9GlcNAc2 glycoprotein that binds to CNX or
CRT (Ou et al., 1993; Zapun et al., 1997). Together with
ERp57 (Frickel et al., 2002; Pollock et al., 2004; Zapun
et al., 1998), this allows for correct formation of the disul-
fide bonds and further maturation of the protein through
glycan processing. A quality control system exists in
which UGGT recognizes unfolded Man9GlcNAc2 glyco-
proteins and reglucosylates them for CNX/CRT binding
and further ERp57 processing. This pathway, known
as the calnexin cycle, is responsible for the folding
of proteins such as viral hemagglutinin, rhodopsin,
transferrin, and major histocompatibility complex MHC
class I molecules (Ou et al., 1993; Rosenbaum et al.,
2006; Solda et al., 2006). Recent evidence suggests
that ERp57 may also play a structural role in the MHC
class I complex with TAP (transporter associated with
antigen processing), where it forms a covalent, disulfide-
linked complex with tapasin (Garbi et al., 2006; Peaper
et al., 2005).
ERp57 (also called ER-60 or GRP58) is composed of
four thioredoxin-like domains abb0a0 with CGHC cata-
lytic motifs in the N- and C-terminal a and a0 domains.
ERp57 is highly similar to PDI both in its domain organi-
zation and sequence. Similarity is highest in the catalytic
a and a0 domains (w50% identity) and lowest in the bb0
domains (20%). ERp57 possesses oxidoreductase ac-
tivity (Bourdi et al., 1995; Hirano et al., 1995; Srivastava
et al., 1993) but is most active when coupled to CNX/
CRT (Zapun et al., 1998). The physical association be-
tween ERp57 and CNX/CRT has been shown by cross-
linking (Oliver et al., 1997, 1999) and by NMR (Frickel
et al., 2002; Pollock et al., 2004), but the mechanism of
CNX/CRT stimulation of ERp57 activity is unknown.
Recently, the X-ray crystal structure of yeast PDI was
reported at 2.4 A˚ (Tian et al., 2006). The structure of PDI
shows an overall U shape with the catalytic sites of the
two active thioredoxin domains facing each other. The
interior surface of the U is hydrophobic and likely con-
tributes to PDI’s ability to bind unfolded proteins and
catalyze the formation of correct disulfides. An NMR
characterization of the a and a0 domains of ERp57 con-
firmed that they adopt a thioredoxin-like fold (Pirne-
skoski et al., 2004; Silvennoinen et al., 2001, 2005).
The structure of the luminal domain of CNX has also
been determined by X-ray crystallography. The protein
is characterized by two main structural components,
a globular lectin domain and an extended proline-rich
structure, termed the P domain (Schrag et al., 2001).
The P domain is composed of four modules which
form a hook-like arm. Previous studies using NMR spec-
troscopy and mutagenesis found that the tip of the P do-
main of CNX or CRT binds to ERp57 (Frickel et al., 2002;
Leach et al., 2002; Pollock et al., 2004).
Here we report structural studies of ERp57 using
a combination of small-angle X-ray scattering (SAXS),
X-ray diffraction, and NMR techniques. We show that
the shape of ERp57 in solution is highly similar to the
crystal structure of yeast PDI but that the 2.0 A˚ X-ray
Structure
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ences in the CNX binding site, determined by NMR
chemical shift mapping. Mutagenesis and in vitro folding
assays demonstrate a requirement for the CNX-ERp57
interaction for efficient glycoprotein folding but not
oxidoreductase activity.
Results
Structure of the bb0 Fragment
We crystallized the bb0 fragment of ERp57 and deter-
mined its three-dimensional structure by X-ray diffrac-
Table 1. Data Collection and Refinement Statistics
Data Collection
Space group P21
Unit cell (A˚) a = 76.3, b = 62.4, c = 99.3
Resolution range (A˚) 50–2.0
Observed reflections 455,000
Unique reflections 121,811
Completeness (%) 99.4 (96.1)
Overall (I/sI) 14.0 (2.6)
Refinement and Model Quality
Resolution range (A˚) 32.7–2.0
Rfree, number of reflections 0.250 (3,162)
Rwork, number of reflections 0.194 (59,353)
Rmsd bond lengths (A˚) 0.025
Rmsd bond angles () 1.932
Average B factors (A˚2),
number of atoms
Protein 43.1 (6,087)
Main chain atoms 42.1 (2,776)
Side chain atoms 43.6 (2,858)
Water 45.7 (453)
Ramachandran plota
% of residues in
Most favorable regions 93.1
Additional allowed regions 6.9
a Laskowski et al. (1993).tion using multiwavelength anomalous diffraction
(MAD) phasing (Table 1). The crystals belong to the
P21 space group and contain three molecules in the
asymmetric unit. The structure was refined to 2.0 A˚ res-
olution (Figure 1A). The chains were traced from P134
(A135 in chain B) to L365. Five N-terminal residues cor-
responding to the cloning linker and the last 15 residues
of the construct including K366–G376 from the linker
following the b0 domain were not present in the electron
density maps, indicating that these parts were disor-
dered in the crystal.
The structure contains two thioredoxin-like domains
connected by a short linker. The b domain extends
from A135 to F241, and the b0 domain from P245 to
Y364 (Figure 2A). The two domains are very similar and
can be superimposed using the backbone atoms of 96
residues with a root-mean-square deviation (rmsd) of
2.8 A˚. Each domain has a central five-stranded b sheet
(Figure 1B). The b sheet has the order of b strands b1-
b3-b2-b4-b5, which are all parallel with the exception
of strand b4. The four a helices of each domain are of
various lengths and enclose the b sheets with two heli-
ces on either side. The a2 helix in the b0 domain (A273–
D292) is significantly longer than any other helix in the
structure. The long loop between strands b4 and b5 of
domain b contains a short a-helical segment (S209–
L211) that interacts with helix a2 of the b0 domain, form-
ing an important part of the b-b0 interface. The b and
b0 domains of ERp57 form an essentially rigid molecule,
and as a result, all three chains in the asymmetric unit
can be superimposed using their entire backbone with
an rmsd of 0.8–1.0 A˚ (Figure 1C). The short three residue
linker between these domains is involved in interdomain
contacts and has temperature factors similar to proxi-
mal regions in both domains.
A structural similarity search using the Dali database
(Holm and Sander, 1995) gave scores that were gener-
ally higher for the b domain, which has higher sequence
similarity to other thioredoxin-like domains. The best
match was the second thioredoxin-like domain fromFigure 1. X-Ray Crystal Structure of the bb0
Fragment of ERp57
(A) Crystal packing of the three molecules in
the asymmetric unit cell.
(B) Secondary structure of the b and
b0 domains.
(C) Overlay of the three molecules showing
the rigidity of the bb0 fragment.
Crystal Structure of the bb0 Fragment of ERp57
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(A) Domain structure of ERp57, showing the four thioredoxin-like domains and the C-terminal polylysine tract (triangle).
(B) Structure-based sequence alignment. Secondary structure elements are shown in red for ERp57 and in light blue for PDI. Asterisks mark the
locations of sequence insertions. Blue triangles mark lysine and arginine residues in ERp57 essential for binding the CNX P domain. Residues in
the b0 domain of ERp57 are underlined.
(C) Two structural superpositions of the b and b0 domains from PDI and ERp57. Asterisks mark the insertions in the b domain of ERp57 (dark red)
and in the b0 domain of PDI (light blue).calsequestrin (Z = 14.9); both domains could be super-
imposed using their backbone atoms of 101 residues
with an rmsd of 1.9 A˚. The tandem of b and b0 domains
superimposed on the calsequestrin structure with an
rmsd of 3.7 A˚ over 204 residues, indicating similar rela-
tive orientation of these domains in calsequestrin. The
similarity of PDI to calsequestrin has been previously
noted (Tian et al., 2006). The closest structural homolog
for the complete bb0 fragment of ERp57 was yeast PDI,
which could be superimposed with an rmsd of 3.5 A˚ (Z =
14.1) over 199 residues.
A structure-based sequence alignment of the bb0
fragments of human ERp57 and yeast PDI highlights
the similarities and differences between the two pro-
teins (Figure 2B). The biggest differences are two 6–7
residue inserts in the b domain and a long deletion in
the b0 domain of ERp57 relative to PDI (Figure 2C).
The first insert comprises helix a3. The second insert
enlarges the b4-b5 loop in the b domain, with impor-
tant structural and functional consequences. In
ERp57, this loop contains residues that participate in
CNX binding (see below). It also creates an extensive
contact surface between the b and b0 domains, not
seen in yeast PDI. As a result, the angle between the
b and b0 domains in ERp57 differs by roughly 15
from the angle in PDI. This loop may also contribute
to the rigidity of the b and b0 pair. In contrast to the
b domain, which is smaller in yeast PDI, the b0 domain
contains an additional helix as part of the loop follow-
ing sheet b50.
Notwithstanding their structural similarity, the bb0 do-
mains of ERp57 and PDI differ significantly in their sur-
face charges. The largest difference is in helix a20 of
the b0 domain, which carries a formal charge of +4 in
ERp57 and 24 in PDI (Figure 2B). The positive charge
of this region of ERp57 likely plays an important role in
its specific binding to the highly negatively charged P
domain of CNX.Small-Angle X-Ray Scattering of Full-Length ERp57
In order to determine the overall shape and domain or-
ganization of ERp57, we carried out an analysis by
small-angle X-ray scattering (SAXS). Small-angle scat-
tering can be used to calculate the radius of gyration
(Rg) and the maximum dimensions of the molecule
(Dmax), but it is also sensitive to the overall shape of a
molecule and can be used to generate molecular shape
reconstructions and test structural models (Koch et al.,
2003). We collected scattering data on full-length
ERp57 with no evidence of aggregation up to 10 mg/ml
(Figure 3A).
Independent support of our SAXS data comes from
two recent papers: a SAXS study of human PDI (Li
et al., 2006) and the crystal structure of yeast PDI (Tian
et al., 2006). Qualitatively, there is good agreement
between the pair distance distribution functions P(r) cal-
culated for ERp57 and human PDI with the presence of
a marked, double-maximum centered around 40 A˚ in
both curves (Figure 3A, insert) (Li et al., 2006). The theo-
retical scattering curve calculated using the yeast PDI
crystal structure and the experimental curve for full-
length ERp57 are also very similar, with a low residual
coefficient c of 4.76 (Figure 3A) (Svergun et al., 1995).
The fit between the scattering curves was quite sensitive
to changes in the angles between the domains in the
atomic model; replacing the bb0 domains of PDI with
the domains from ERp57 did not improve the fit. While
the yeast PDI structure suggests that the a and
a0 domains are relatively mobile (Tian et al., 2006), our
SAXS data imply that, at low resolution, the average
conformation of ERp57 in solution closely resembles
the PDI crystal structure.
The program GASBOR (Svergun et al., 2001) was used
to generate structural models based on the ERp57 SAXS
data. The program uses simulated annealing to match
the experimental data to a computed scattering curve
from a pseudoatom model. The models, consisting of
Structure
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(A) Fit of the experimental ERp57 scattering data (red) and the scattering curve calculated from the PDI X-ray structure (green). R(g) = 31.5. The
insert shows the experimental P(r) plot.
(B) Pseudo-atom reconstruction (GASBOR) of ERp57 superposed on the X-ray structure of yeast PDI (Tian et al., 2006). The domains of PDI are
labeled. In the lower view, the a domain is hidden on the backside and not labeled.one scatterer (pseudoatom) per amino acid, were
aligned, averaged, and filtered based on occupancy
using DAMAVER (Volkov and Svergun, 2003) to obtain
a ‘‘most probable’’ model, which clearly shows four
globular domains (Figure 3B).
Superposition of the yeast PDI X-ray structure and
DAMAVER model shows that the relative positions of
the domains observed in the crystal are conserved in
ERp57 in solution. Most notably, both structures have
an overall U shape and place the two catalytically active
domains a and a0 on one side of the molecule and the
b and b0 domains on the other (Figure 3B).
Identification of Individual Residues in the CNX
Binding Site
The high-quality spectra of the b0 domain of ERp57 al-
lowed us to use NMR to identify the CNX binding site.
The 1H-15N HSQC spectrum was characteristic of a
folded, well-behaved protein with good signal disper-
sion (see Figure S1 in Supplemental Data available with
this article online). Complete backbone resonance as-
signments for the b0 domain were obtained using stan-
dard triple-resonance experiments on a doubly (15N,
13C) labeled sample. Titration of 15N-labeled b0 domain
with unlabeled CNX P domain residues P310–K381
caused amide chemical shift changes for residues
D266 (0.25 ppm), V267 (0.20 ppm), A273 (0.14 ppm),
R280 (0.18 ppm), N281 (0.23 ppm), and R344 (0.17
ppm). These lie in the region following strand b20, in the
long helix a2 and the region preceding helix a40 (Fig-
ure 4B). Other residues in this region such as K274,
N277, Y278, and W279 may be involved in binding, but
their chemical shift changes could not be measured
because of overlapping or missing peaks.
Analysis of surface charge distribution reveals that the
chemical shift changes localize to a large positively
charged patch of residues (Figure 4C). This was not sur-
prising, as the tip of the P domain is highly acidic and
would be expected to interact electrostatically with a
positively charged surface. This area also correspondsto the highest sequence conservation in thebb0 domains
across ERp57 proteins from other species (Figure 4D).
Among the most conserved, surface-accessible resi-
dues are the basic amino acids: K214, K274, and R282.
The corresponding surface and residues in theb0 domain
of yeast PDI are negatively charged, consistent with its
lack of interaction with CNX (Figure 2B).
Mutagenesis Confirms the Binding Site
Isothermal titration calorimetry (ITC) was used to mea-
sure the binding between different fragments of ERp57
and CNX (Figure 5). Full-length ERp57 binds to the two-
module P domain fragment of CNX with an affinity of
26 mM. The binding is exothermic, which reflects favor-
able van der Waals, hydrogen bond, and electrostatic in-
teractions. These results are comparable to the binding
of ERp57 to CRT, also measured by ITC (Frickel et al.,
2002). The affinity of the P domain for the bb0 fragment
was slightly higher than for full-length ERp57. This could
reflect greater accessibility of the binding site in the bb0
fragment. The smallest ERp57 fragment that bound the
P domain was the b0 domain, which bound with 50 times
lower affinity. Together, these measurements demon-
strate that the b0 domain contains the principal elements
for ERp57 binding to CNX, while the b domain provides
additional contacts necessary for high affinity.
To verify the identification of the CNX binding site, we
generated site-directed alanine substitution mutants
and tested their binding using NMR and ITC. Two mu-
tants, K274A and R282A, were designed to remove elec-
trostatic interactions in the conserved, basic surface
of the b0 domain. We generated a K214A mutant in the
b domain to test the role of the b4-b5 loop in binding.
As a negative control, a lysine residue (K332) on the
opposite side of the b0 domain was mutated to alanine
(Figure 5A).
The specificity of the P domain-ERp57 interaction was
also tested with an M347A mutation in the two-module P
domain of CNX. This conserved residue occurs at the tip
of the P domain and shifts in HSQC spectra upon bb0
Crystal Structure of the bb0 Fragment of ERp57
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has never been tested. All the mutant proteins were cor-
rectly folded, as verified by 1D NMR spectra and com-
parison with spectra for the corresponding wild-type
fragments (Figures S3–S5).
Mutation of either R282 in ERp57 or M347 in CNX
completely abrogated binding, as measured by ITC
and NMR titrations. Both mutations caused a >1000-
fold loss in affinity based on the upper limit (w5 mM)
for detecting binding by NMR. Less dramatic effects
were observed with the K214A mutation, which showed
an 8-fold loss of affinity (Figure 5C). The side chain of
K214 appears to be the most important recognition ele-
ment in the b domain, as its deletion accounted for over
Figure 4. Identification of the CNX Binding Site on ERp57
(A) Plot of chemical shift changes in the 15N-labeled ERp57b0 domain
upon addition of unlabeled CNX P domain.
(B) Mapping of the chemical shifts onto the bb0 structure. Red indi-
cates a large chemical shift change, white indicates no change, and
gray indicates no data. The largest changes in the lower b0 domain
are labeled.
(C) Electrostatic potential of bb0 showing the abundance of basic
residues in the P domain binding site. The right-hand surface is in
the same orientation as the representation in (B); the left-hand
surface is rotated by 180.
(D) Sequence conservation of surface residues on the ERp57 bb0 do-
mains. Highly conserved residues in 50 protein sequences most
closely related to human ERp57 are shown in green. The P domain
binding site corresponds to the largest area of conserved amino
acid residues.half of the effect of deletion of the entire b domain. The
K332A mutant showed binding affinity identical to
wild-type, confirming that binding is specific and is not
related to the overall charge of the bb0 domains.
ERp57-CNX Interaction Is Essential for In Vitro
Folding of RNase B
We studied the competence of ERp57 and CNX for cat-
alyzing protein folding in vitro using RNase B as a model
substrate and low-pH native gels (Zapun et al., 1998).
Folding occurs in an ER-like redox buffer containing
the luminal domain of CNX and full-length ERp57. The
required substrate Glc1 RNase B carries a single N-gly-
can of the form Glc1Man8–9GlcNAc2 at Asn34. This Glc1-
labeled RNase B is specifically bound by the lectin
domain of CNX (Zapun et al., 1997), which stimulates
the disulfide exchange activity of ERp57 to refold the
substrate.
As previously reported (Zapun et al., 1998), the folding
reaction is dependent on the presence of the terminal
glucose residue on the substrate. The commercial
source of RNase B contains w90% of Man5–7GlcNAc2
RNase B, which cannot be labeled with 3H-glucose by
UGGT. This unlabeled RNase B can be visualized in
the gel assay by Coomassie blue staining and remains
mostly unfolded after 80 min (Figure 5D, CB). 3H-gluco-
sylated RNase B, when incubated with wild-type ERp57
and CNX, was largely folded after 40 min (Figure 5D, AR).
The ability of the ERp57-CNX complex to mediate
folding of 3H-labeled RNase B was completely depen-
dent on a functional interaction between ERp57 and
CNX. The point mutants K214A, K274A, and R282A of
full-length ERp57 were compromised in their ability to
fold Glc1-labeled RNase B (Figure 5D). Similarly, omis-
sion of either CNX or ERp57 from the reaction led to
only a minor amount of spontaneous folding of RNase
B, comparable to that observed with unlabeled RNase
B (Figure 5D). In contrast, the K332A mutant, which
does not affect CNX binding, catalyzed rapid folding.
As a control for nonspecific effects, we examined the
NMR spectra of the mutant proteins and characterized
their thiol reductase activity against a small-molecule
substrate, di(o-aminobenzyl)-labeled oxidized glutathi-
one (diabz-GSSG) (Raturi et al., 2005). All of the ERp57
mutants were folded (Figures S4 and S5) and had full
reductase activity (our unpublished data). Significantly,
the addition of the luminal domain of CNX or the two-
module P domain did not stimulate ERp57 activity
toward diabz-GSSG (Figure S6).
Discussion
The X-ray structure of the bb0 domains provides atomic
resolution details of the CNX binding site on ERp57. This
site consists of a large positively charged patch of highly
conserved residues (K214, K274, and R282) that are
essential for the function of ERp57. These residues en-
gage the negatively charged residues of the CNX P do-
main, which along with the critical methionine residue
(M347) comprise the tip of the P domain. While the
b0 domain provides the majority of the binding site, the
b4-b5 loop of the b domain affords additional contacts
(K214) with the P domain, strengthening the interaction.
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(A) Structure of ERp57 bb0 domains showing space-filling models of the residues mutated.
(B) ITC thermogram of the interaction of the CNX two-module P domain binding to the bb0 domains of ERp57.
(C) Table of ITC binding affinity constants for wild-type and mutant proteins.
(D) In vitro refolding assays of RNase B with wild-type and mutant ERp57 proteins and the luminal domain of CNX. 3H-glucose-labeled RNase B
was refolded for the time indicated and run on low-pH nondenaturing PAGE. Autoradiograms (AR) show the relative amounts of natively folded
(N) and unfolded (U) 3H-Glc1-RNase B. For the wild-type assay, the Coomassie blue (CB)-stained gel shows the spontaneous folding of unlabeled
RNase B. The right panels show autoradiograms at 80 min for four mutant ERp57 proteins and negative controls where CNX or ERp57 was omit-
ted from the folding reaction.Mutations previously shown to compromise the
ERp57-CRT interaction (V267, Y269, K274, R280, N281,
and F299) correlate well with our results (Russell et al.,
2004). Among these, K274, R280, and N281 are surface
exposed and likely hydrogen bond with the negatively
charged P domain. Y269 is partially surface accessible
and could form part of a hydrophobic pocket at the
base of the b20-a20 loop for the binding of M347 of CNX.
On the other hand, V267 and F299 are both buried in
the hydrophobic core and are unable to directly interact
with the P domain. These mutations are both located un-
der helix a20 and may affect binding via indirect contacts
or through distortion of the b-b0 interdomain interface.
Intriguingly, the CNX binding site in the b0 domain cor-
responds to the position of the catalytic cysteines in the
b2-a2 loop of thioredoxins and the primary peptide bind-
ing site in the b0 domain of PDI (Pirneskoski et al., 2004).
This supports earlier suggestions that the substrate
binding domains in protein disulfide isomerases were
created through gene duplication of catalytic domains
and evolutionary modification of their active sites (loss
of the catalytic cysteines) to favor protein binding (Kanai
et al., 1998).
Our SAXS results demonstrate that the solution struc-
ture of ERp57 is highly similar to the crystal structure of
PDI from yeast. This places the CNX binding site on theopposite face of ERp57 relative to the catalytic thiols
(Figure 6). The long hook-like P domain is ideally shaped
to curve around ERp57 and position the lectin binding
site of CNX next to the catalytic a and a0 domains. The
SAXS model also suggests that the positively charged
C terminus of ERp57 is too far from the CNX binding
site on the b0 domain of ERp57 to participate in direct
binding of the P domain. This basic stretch, previously
identified as interacting with CNX (Pollock et al., 2004),
may interact with the phospholipid membrane, thus
affecting binding of CNX and the efficiency of ERp57-
mediated protein folding. In PDI, the C-terminal sequence
is acidic and forms a highly solvent-exposed a helix.
How does the CNX-ERp57 complex work to fold pro-
teins? The long distance (>40 A˚) between the CNX
binding site and the catalytic cysteines argues against
a CNX-induced conformational change or direct stimu-
lation of the oxidoreductase activity of the a and
a0 domains. Instead, the structure of ERp57 suggests
that CNX serves to bind and position substrates next
to the catalytic cysteines. The loss of either glycoprotein
binding to CNX or CNX binding to ERp57 abrogates
ERp57-catalyzed protein folding. Because the reactions
done here are performed at low substrate concentra-
tions, decreasing the KM of the folding reaction has the
same effect as a stimulation of the reaction Vmax. More
Crystal Structure of the bb0 Fragment of ERp57
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elucidate the functional aspects of the CNX-ERp57
interaction.
Experimental Procedures
Protein Expression, Preparation, and Purification
Full-length human ERp57 lacking the signal sequence (A24–L505)
and the bb0 (P134–G376) and b0 (F241–G376) fragments were cloned
as GST fusions between the BamH1 and Not1 sites of pGEX-6P-1
(Amersham Pharmacia) and expressed in Escherichia coli
BL21(DE3). To prepare labeled protein for NMR experiments, cells
were grown in M9 minimal medium with 15N-NH4Cl and
13C-U-glu-
cose. Selenomethionine-labeled protein was produced in the
E. coli methionine auxotroph DL41(DE3) grown on LeMaster me-
dium (Hendrickson et al., 1990). The GST fusion proteins were puri-
fied by affinity chromatography on glutathione-Sepharose resin and
tags were removed by cleavage with Prescission protease, leaving
N-terminal Gly-Pro-Leu-Gly-Ser and C-terminal Ala-Ala-Ala-Ser ex-
tensions. The cleaved protein was additionally purified using size
exclusion chromatography and concentrated using Centricon 3000
concentrators. The P domain two-module fragment of canine CNX
(residues 310–381) was expressed and purified as described
(Pollock et al., 2004). The luminal domain of canine CNX (Ou et al.,
1995) and recombinant rat UDP-glucose:glycoprotein glucosyl-
transferase (UGGT) (Tessier et al., 2000) were expressed in a baculo-
virus/sf9 insect cell system as described previously (Zapun et al.,
1998). Estimates of protein concentrations were based on theoreti-
cal UV absorption coefficients.
Preparation of CNX and ERp57 Point Mutants
Mutants were prepared by Quickchange site-directed mutagenesis
(Stratagene) with mismatched primers and verified by DNA se-
quencing.
SAXS
Small-angle X-ray scattering data were collected at beamline 12.3.1
at the Advanced Light Source (Lawrence Berkeley National Labora-
tory, Berkeley, CA) with protein concentrations of 2, 5, and 10 mg/ml.
Data were scaled by using the program PRIMUS (Konarev et al.,
2003) and analyzed by the programs GNOM (Svergun, 1992) and
CRYSOL (Svergun et al., 1995). Radii of gyration (Rg) were computed
Figure 6. Model of Full-Length ERp57
The a and a0 domains from the yeast PDI structure (light gray) were
positioned on the bb0 fragment of ERp57 (dark gray) to show the rel-
ative positions of the thiol reactive cysteine residues (yellow) and the
three basic residues, K214, K274, and R282, of the CNX binding site
(blue).from the Guinier plot by using PRIMUS, GNOM, and CRYSOL. The
pair distance distribution function (P[r]) was calculated by using
the program GNOM. Scattering curves and the goodness of fit (c)
based on atomic models were obtained by using CRYSOL.
Crystallization
Crystals were obtained by the hanging drop equilibration of 14 mg/ml
protein in 50 mM Tris-HCl, 0.15 M NaCl, 1 mM DTT (pH 7.5) against
30% (w/v) PEG3350, 0.1 M (NH4)2SO4, 0.1 M HEPES buffer (pH 7.5)
for 1–3 days at 20C.
Structure Solution and Refinement
Three-wavelength MAD data were collected at beamline X8C at the
National Synchrotron Light Source, Brookhaven National Labora-
tory (Table 1) and processed with HKL2000 (Otwinowski and Minor,
1997) and d*TREK (Pflugrath, 1999). The structure was determined
using SHELXC/D/E (Sheldrick and Schneider, 1997) and ARP/
wARP (Perrakis et al., 1997). Data to 2.1 A˚ resolution at the peak
wavelength (0.9795 A˚) were used to locate Se atoms with a figure
of merit = 0.66. Density modification with the program ARP/wARP
(Perrakis et al., 1997) allowed automated model building of w75%
of the residues. The partial model obtained from ARP/wARP was
extended manually with O (Jones et al., 1991) and improved by re-
finement using REFMAC (Murshudov et al., 1999) with the translation
libration screw (TLS) option (Winn et al., 2003). Figures were pre-
pared with PyMOL (Delano, 2002) and GRASP (Nicholls et al.,
1991). The protein contact potential was calculated by PyMOL using
default vacuum electrostatics ranging and color coded from280 kT
(red) to 80 kT (blue), where k is the Boltzmann constant and T is tem-
perature. Coordinates have been deposited in the RCSB Protein
Data Bank under ID code 2H8L.
NMR Spectroscopy
NMR resonance assignments of the b0 fragment of ERp57 in 50 mM
Na2HPO4, 100 mM NaCl, 1 mM DTT (pH 6.8) were carried out using
HNCACB, CBCA(CO)NH, HNCA, and 15N-noesy-HMQC experiments
at 30C at 500, 600, and 800 MHz. Amide signal assignments have
been deposited in the Biological Magnetic Resonance Bank under
ID code BMRB-7162.
Isothermal Titration Calorimetry Measurements
Experiments were carried out on a MicroCal VP-ITC titration calo-
rimeter (MicroCal, Northampton, MA) in 50 mM Tris-HCl, 100 mM
NaCl, 1 mM NaN3 (pH 6.8) at 15
C. Data were processed using
ORIGIN and the binding isotherm was fit to a single-site binding
model to determine the binding constant.
RNase B Folding
The RNase B folding assay was carried out as previously described
(Zapun et al., 1998) with noted changes. The Glc1 form of RNase B
was prepared from Man8GlcNAc2 or Man9GlcNAc2 RNase B (Sigma)
using UGGT and 3H-UDP-glucose. Briefly, 500 mg of RNase B was
unfolded and reduced for 20 min at room temperature in 0.1 M
Tris-HCl (pH 8.0) containing 6 M guanidine HCl and 20 mM DTT. Un-
folded RNase B was desalted in 0.1% formic acid on a NAP-5 col-
umn (Amersham Biosciences) and lyophilized. RNase B (z120 mM)
was then glucosylated with 5–15 mM, 10–30 mCi/mmol [3H]UDP-glu-
cose using a crude concentrate of recombinant rat UGGT expressed
in sf9 insect cells (Tessier et al., 2000) in 25 mM HEPES, 5 mM CaCl2
containing 200 mM 1-deoxynojirimycin for 2 hr at 37C. For each
folding assay, the labeling reaction was adjusted to 150 mM NaCl,
2.5 mM CaCl2, 0.5 mM oxidized glutathione, 2 mM reduced glutathi-
one containing 24 mM purified calnexin luminal domain (Ou et al.,
1995) and 8 mM ERp57 or its mutants and incubated at room temper-
ature. Time points were taken by blocking free thiols with 0.25 vol-
umes of 0.5 M iodoacetamide in 1.5 M Tris-HCl (pH 8.7) and storing
on ice before analyzing by low-pH nondenaturing PAGE (Creighton,
1979). Gels were Coomassie stained, destained, and treated with
Amplify (Amersham Biosciences) for 30 min before drying and
exposing to Kodak Biomax MS film for 24–96 hr.
Supplemental Data
Supplemental data include six figures showing the identification of
the ERp57 binding site on the CNX P domain, 2D NMR spectrum
Structure
1338of the b0 domain of CNX, 1D NMR spectra of the point mutants in the
CNX P domain, ERp57 bb0 domains, full-length ERp57 showing that
they are correctly folded, and results of GSSG reduction by ERp57.
Supplemental data are available at http://www.structure.org/cgi/
content/full/14/8/1331/DC1.
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